VKORC1 is a gene that influences vitamin K activity and sensitivity to anticoagulants like warfarin. During menopause, hormonal shifts affect bone health and cardiovascular risk. Vitamin K is involved in bone mineralization (via osteocalcin) and vascular calcification (via matrix Gla protein). In theory, VKORC1 variants could modulate vitamin K utilization and thus indirectly impact these processes. However, the evidence is mostly mechanistic; there are no robust clinical studies directly linking VKORC1 to menopausal symptoms or long-term outcomes. If you are taking warfarin, VKORC1 testing is relevant for dosing. Otherwise, the benefit of such testing during menopause is unclear. MyBody-X does not offer a specific analysis for VKORC1 in the context of menopause. Consult your doctor for any health concerns.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-729ede3a2860895300e7fe7e